NI
Nextech Invest Portfolio holdings
AUM
$657M
1-Year Est. Return
8.71%
1 Year Est. Return
+8.71%
AUM
$657M
AUM Growth
+$129M
(+24%)
Holding
16
Top Buys
No buys this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$14.7B
| $355M | 54.03% |
7,601,087
|
|
||
2
Oric Pharmaceuticals
ORIC
$1.11B
| $86M | 13.08% |
7,162,637
|
|
||
3
Tyra Biosciences
TYRA
$1.13B
| $56.7M | 8.64% |
4,055,861
|
|
||
4
Tango Therapeutics
TNGX
$1.4B
| $46.5M | 7.08% |
5,533,980
|
|
||
5
Relay Therapeutics
RLAY
$1.3B
| $20.1M | 3.06% |
3,846,409
|
|
||
6
Kymera Therapeutics
KYMR
$4.82B
| $19.3M | 2.94% |
340,909
|
|
||
7
Zymeworks
ZYME
$1.97B
| $19M | 2.9% |
1,113,946
|
|
||
8
Arvinas
ARVN
$764M
| $12M | 1.83% |
1,408,394
|
|
||
|
ALMS
9
Alumis Inc
ALMS
$766M
| $11.6M | 1.77% |
2,915,998
|
|
||
10
Context Therapeutics
CNTX
$102M
| $7.19M | 1.09% |
7,419,355
|
|
||
11
Cullinan Oncology
CGEM
$628M
| $6.77M | 1.03% |
1,141,145
|
|
||
12
ARS Pharmaceuticals
SPRY
$914M
| $6.64M | 1.01% |
660,703
-81,026
|
|
||
|
SLN
13
Silence Therapeutics
SLN
$307M
| $4.94M | 0.75% |
952,400
|
|
||
14
Mersana Therapeutics
MRSN
$138M
| $3.75M | 0.57% |
482,689
-1
|
|
||
|
BOLD
15
Boundless Bio
BOLD
$24.8M
| $1.51M | 0.23% |
1,228,069
|
|
||
|
CRGX
16
DELISTED
CARGO Therapeutics
CRGX
| – | – |
-2,642,502
|
|